Category Archives: RESEARCH, STUDIES, DOCUMENTATION
Historical Time Line of infectious disease outbreaks caused by VACCINES
-In 1979, Sweden abandoned the whooping cough vaccine due to its ineffectiveness. Out of 5,140 cases in 1978, it was found that 84% had been vaccinated three times! (BMJ 283:696-697, 1981)
-In the UK between 1970 and 1990, over 200,000 cases of whooping cough occurred in fully vaccinated children. (Community Disease Surveillance Centre, UK)
– In the 1970s, a tuberculosis vaccine trial in India involving 260,000 people revealed that more cases of TB occurred in the vaccinated than the unvaccinated. (The Lancet 12/1/80 p73) Read more…
THIMEROSAL: Secret CDC Verstratten Study shows neurological developmental disorders with Mercury/Vaccines
Activist Post Vaccine Dangers: BOOMSHELL Admissions form CDC 1999 Note: The Co Med website is wrong. This is the correct one:
Finally! After all these years of denial and damage, the truth about ethylmercury in the form of Thimerosal (49.6%) in vaccines has been revealed to a member of the U.S. Congress as a result of oversight requests that were sent to the U.S. Centers for Disease Prevention and Control (CDC) and shared with one of the foremost research groups regarding mercury in drugs, CoMeD, whose website is www.mercury-freedrugs.org Read original abstract
Comment by Jim Moody, attorney, SafeMinds.org
“This looks like the “generation zero” [earliest] version of what came to be fraudulently published n 2003 as the Verstratten et al study in Pediatrics. This “study” was heavily used the OAP but has pretty much completely disappeared from the CDC website.
Here is more detail on the documents we got from an early FOIA request including early emails from Verstrateten: Click here
Jim Moody’s correspondence inside emails
FDA approves research for Cannaboids (Marijuana) for Seizures, Inflamatory Conditions, Pediatric Epilepsy & Dravet Syndrome
FDA Approves Investigational Trials Assessing Cannabidiol For Pediatric Epilepsy
Washington, DC: The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric epilepsy. The two approved trials will take place at New York Medical School and at the University of California at San Francisco, according to an online report in the journal O’Shaughnessy’s. The cannabidiol formulations in the trials will be provided by British biotechnology firmGW Pharmaceuticals, which produces organic cannabinoid extract medicines, including Sativex. Will doctors throughout the U.S. be called on to submit INDs on behalf of pediatric epilepsy patients whose families want access to Epidiolex™? Interested doctors should direct inquiries to GW’s Associate Medical Director at medicaldirector@gwpharm.com.
Cannabidiol has been documented to possess a variety of therapeutic properties in preclinical models, including anti-epileptic activity. Clinical trials have shown the oral administration of CBD to be “safe and well tolerated” in healthy subjects.
In recent months, several national broadcasts have highlighted the use of CBD-rich oils to treat seizures associated with a pediatric form of intractable epilepsy known as Dravet Syndrome. Read more…
STUDY: Healthcare Workers who get flu shots give patients greater risk of other respiratory infections.
Rabies: The Girl Who Survived Rabies
REPORT YOUR DRUG SIDE EFFECTS – TO THE GOOD GUY RESEARCHERS & MEDICAL TEAM
Our Medical and Research Team
There are few professionals who have the profile and international reputation of our founding team, which includes people who have risked their careers in speaking out about adverse drug events, such as David Healy and Nancy Olivieri, as well as international experts on pharmaco-vigilance such as Ralph Edwards from World Health Organization’s Uppsala Monitoring Center.
OXFORD JOURNAL: Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine
115 children were randomized to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.”
Autism: 22 studies linking vaccines to autism (Activist Post)
Here is a great video narrated by Rob Schneider outlining the vaccine-autsim link. Click the read more link and you will find a list of 22 medical studies that show viable connections to vaccines and autism. Please keep in mind that there is only presented 22 studies here, there are many more published papers that document the link. Read more…
Dr. SherrI Tenpenny: Responds to UNICEF putting her on the ANTI-VACCINE HIT LIST
Dr. Tenpenny TELLS IT LIKE IT IS – Doctor of Osteopathy (medical doctor), discusses her place on the UNICEF hit list and why parents are increasingly against vaccines.
Join Dr. Tenpenny’s Vaccine Research Library loaded with conventional medical studies recording the problems with vaccines.


